Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Pelkonen

Showing results (231-240 of 275) with videos related to

Pageof 28
Sort By:
Journal of Biochemical Toxicology|January 1, 1989
Comparison of the formation of benzo[a]pyrene diolepoxide-DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2K Vähäkangas, H Raunio, M Pasanen, et al.
Biokhimiia (Moscow, Russia)|May 1, 1990
[Cholesterol-hydroxylating cytochrome P-450 from bovine adrenal cortex mitochondria and human placenta: immunochemical properties and structural characteristics]S A Usanov, A A Chernogolov, P Honkakoski, et al.
Clinical Pharmacology and Therapeutics|November 3, 1998
CYP2D6 polymorphism is not crucial for the disposition of selegilineH Scheinin, M Anttila, M L Dahl, et al.
European Journal of Pharmacology|January 3, 1994
Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitorsP Pellinen, P Honkakoski, F Stenbäck, et al.
Acta Medica Scandinavica|January 1, 1983
Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme inductionP V Luoma, M J Savolainen, E A Sotaniemi, et al.
British Journal of Clinical Pharmacology|December 1, 1984
Drug metabolism in diabetic subjects with fatty liversH I Pirttiaho, P I Salmela, E A Sotaniemi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1997
Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomesH Kim, R S Wang, E Elovaara, et al.
Pharmacology & Toxicology|February 1, 1993
Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lungP Honkakoski, J Mäenpää, J Leikola, et al.
Clinical Pharmacology and Therapeutics|July 1, 1986
Fibrotic process and drug metabolism in alcoholic liver diseaseE A Sotaniemi, O Niemelä, L Risteli, et al.
British Journal of Pharmacology|February 28, 2007
New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysisL E Korhonen, M Turpeinen, M Rahnasto, et al.
Pageof 28

Showing results (231-240 of 275) with videos related to

Sort By:
Pageof 28
Journal of Biochemical Toxicology|January 1, 1989
Comparison of the formation of benzo[a]pyrene diolepoxide-DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2K Vähäkangas, H Raunio, M Pasanen, et al.
Biokhimiia (Moscow, Russia)|May 1, 1990
[Cholesterol-hydroxylating cytochrome P-450 from bovine adrenal cortex mitochondria and human placenta: immunochemical properties and structural characteristics]S A Usanov, A A Chernogolov, P Honkakoski, et al.
Clinical Pharmacology and Therapeutics|November 3, 1998
CYP2D6 polymorphism is not crucial for the disposition of selegilineH Scheinin, M Anttila, M L Dahl, et al.
European Journal of Pharmacology|January 3, 1994
Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitorsP Pellinen, P Honkakoski, F Stenbäck, et al.
Acta Medica Scandinavica|January 1, 1983
Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme inductionP V Luoma, M J Savolainen, E A Sotaniemi, et al.
British Journal of Clinical Pharmacology|December 1, 1984
Drug metabolism in diabetic subjects with fatty liversH I Pirttiaho, P I Salmela, E A Sotaniemi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1997
Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomesH Kim, R S Wang, E Elovaara, et al.
Pharmacology & Toxicology|February 1, 1993
Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lungP Honkakoski, J Mäenpää, J Leikola, et al.
Clinical Pharmacology and Therapeutics|July 1, 1986
Fibrotic process and drug metabolism in alcoholic liver diseaseE A Sotaniemi, O Niemelä, L Risteli, et al.
British Journal of Pharmacology|February 28, 2007
New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysisL E Korhonen, M Turpeinen, M Rahnasto, et al.
Pageof 28